- Home
- BROS vs HALO Comparison
BROS vs HALO Comparison
Compare BROS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROS
- HALO
- Stock Information
- Founded
- BROS 1992
- HALO 1998
- Country
- BROS United States
- HALO United States
- Employees
- BROS N/A
- HALO N/A
- Industry
- BROS Restaurants
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BROS Consumer Discretionary
- HALO Health Care
- Exchange
- BROS Nasdaq
- HALO Nasdaq
- Market Cap
- BROS 5.4B
- HALO 6.4B
- IPO Year
- BROS 2021
- HALO N/A
- Fundamental
- Price
- BROS $59.74
- HALO $54.80
- Analyst Decision
- BROS Strong Buy
- HALO Buy
- Analyst Count
- BROS 11
- HALO 9
- Target Price
- BROS $58.00
- HALO $60.89
- AVG Volume (30 Days)
- BROS 2.4M
- HALO 1.6M
- Earning Date
- BROS 02-19-2025
- HALO 02-18-2025
- Dividend Yield
- BROS N/A
- HALO N/A
- EPS Growth
- BROS 711.34
- HALO 61.71
- EPS
- BROS 0.32
- HALO 3.02
- Revenue
- BROS $1,192,352,000.00
- HALO $947,355,000.00
- Revenue This Year
- BROS $32.74
- HALO $23.12
- Revenue Next Year
- BROS $21.61
- HALO $15.48
- P/E Ratio
- BROS $184.94
- HALO $18.13
- Revenue Growth
- BROS 30.53
- HALO 21.35
- 52 Week Low
- BROS $25.46
- HALO $33.15
- 52 Week High
- BROS $61.33
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- BROS 63.96
- HALO 67.38
- Support Level
- BROS $54.79
- HALO $52.23
- Resistance Level
- BROS $59.18
- HALO $55.79
- Average True Range (ATR)
- BROS 2.42
- HALO 1.53
- MACD
- BROS 0.21
- HALO 0.74
- Stochastic Oscillator
- BROS 83.44
- HALO 88.03
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments company-operated shops and franchising and other.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.